Pharmatech Ltd

Activities: Design & Build HVAC Manufacturing Packaging Regulatory Research & Development

Trending Articles

  1. Preparing for the future of contained oncology drug production Advancements in oncology drug production, containment technologies, and automation have manifestly improved the safety, efficiency, and precision aspects of manufacturing...
  2. Continuous innovation: redefining the future of pharmaceutical manufacturing In an industry in which reliability is paramount and change can be slow, GEA has consistently proven that innovation and stability go hand in hand. Almost two decades ago, GEA...
  3. Touchlight named most innovative new manufacturing facility at ISPE 2025 Facility of the Year Awards The company’s restored Victorian waterworks site in Hampton, London, has been recognised for transforming DNA manufacturing with its enzymatic, cell-free dbDNA platform
  4. AstraZeneca to expand Virginia manufacturing facility with $4.5bn investment, creating 3600 jobs AstraZeneca will develop a state-of-the-art manufacturing facility in Albemarle County, Virginia, producing a broader range of medicines, including weight management, metabolic...
  5. Optimised fittings for microfluidic systems Miniature flat-bottom ports combine convenience and performance for precise fluid control

Upcoming event

CPHI Frankfurt 2025

28–30 October 2025 | Exhibition | Frankfurt, Germany See all

Related Content

Manufacturing

Pharmatech enters alliance with Integra Continuous Manufacturing

The partnership will provide a complete package of services and a proven roadmap for success to address the technical and experiential gaps
Manufacturing

Anticipate future challenges early, Pharmatech urges

”Don’t be left short-changed post approval – plan in change orders early for accelerated pathways,” Stephanie Gaulding said in her keynote address at CPHI North America
Research & Development

Pharmatech appoints Krystyna Kowalczyk as Chief Operating Officer

To further enhance the company's expertise in clinical oncology trials
Research & Development

Actavis to divest Pharmatech to TPG

TPG to focus on growth and development of innovative products
Subscribe now